493 Distinct correlative signatures of CD4<sup>+</sup> helper and regulatory T cells associate with response to different neoadjuvant immune checkpoint inhibitor combinations in HNSCC
Matthias Brand(UPMC Hillman Cancer Center), Robert L. Ferris(University of Pittsburgh), Joy Marion(UPMC Hillman Cancer Center), Lazar Vujanović(UPMC Hillman Cancer Center), Gabriel Sica(Emory University), Riyue Bao(University of Pittsburgh), Dan P. Zandberg(University of Pittsburgh Medical Center), Housaiyin Li(University of Pittsburgh), Mark Kubik(UPMC Hillman Cancer Center), Brian R. Isett(UPMC Hillman Cancer Center), Tullia C. Bruno(University of Pittsburgh), Umamaheswar Duvvuri(City University of New York), Simion I. Chiosea(University of Pittsburgh), Aditi Kulkarni(University of North Carolina at Chapel Hill), Anthony R. Cillo(University of Pittsburgh), Jing Wang(Unknown), Seungwon Kim(UPMC Hillman Cancer Center), Fei Tu(Key Laboratory of Guangdong Province), P.M.L. Santos(Universidade do Extremo Sul Catarinense), Dario A.A. Vignali(University of Pittsburgh)
Cited by 0
Related Papers
Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck
|New England Journal of Medicine|2016|5.1k
B7-H3: A costimulatory molecule for T cell activation and IFN-γ production
|Nature Immunology|2001|1k
Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients
|Proceedings of the National Academy of Sciences|2017|899